Syngene's MD & CEO On Q2 And Remdesivir Drug Launch

Syngene has started producing Remdesivir drug & hopes to start distribution some time in the third quarter. Niraj Shah speaks to the company's MD & CEO Jonathan Hunt to find out more about the drug & Q2. #Q2WithBQ
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.